Global Gastrointestinal Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Gastrointestinal market size is predicted to grow from US$ 36260 million in 2025 to US$ 44370 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.
Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.
Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.
In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.
LPI (LP Information)' newest research report, the “Gastrointestinal Industry Forecast” looks at past sales and reviews total world Gastrointestinal sales in 2024, providing a comprehensive analysis by region and market sector of projected Gastrointestinal sales for 2025 through 2031. With Gastrointestinal sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastrointestinal industry.
This Insight Report provides a comprehensive analysis of the global Gastrointestinal landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gastrointestinal portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastrointestinal market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastrointestinal and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastrointestinal.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Gastrointestinal market size is predicted to grow from US$ 36260 million in 2025 to US$ 44370 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.
Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.
Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.
In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.
LPI (LP Information)' newest research report, the “Gastrointestinal Industry Forecast” looks at past sales and reviews total world Gastrointestinal sales in 2024, providing a comprehensive analysis by region and market sector of projected Gastrointestinal sales for 2025 through 2031. With Gastrointestinal sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastrointestinal industry.
This Insight Report provides a comprehensive analysis of the global Gastrointestinal landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gastrointestinal portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastrointestinal market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastrointestinal and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastrointestinal.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Prescription Gastrointestinal Drug
- OTC Gastrointestinal Drug
- Chronic Gastritis
- Functional Dyspepsia
- Peptic Ulcer
- Acute Gastroenteritis
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZenec
- Sanofi
- Bayer
- Pfizer
- GlaxoSmithKline
- Teva
- Zeria?Tillotts?
- Perrigo
- Boehringer Ingelheim
- Purdue Pharma
- C.B. Fleet
- Abbott
- Jiangzhong
- Xian-Janssen
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastrointestinal Market Size (2020-2031)
2.1.2 Gastrointestinal Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Gastrointestinal by Country/Region (2020, 2024 & 2031)
2.2 Gastrointestinal Segment by Type
2.2.1 Prescription Gastrointestinal Drug
2.2.2 OTC Gastrointestinal Drug
2.3 Gastrointestinal Market Size by Type
2.3.1 Gastrointestinal Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Gastrointestinal Market Size Market Share by Type (2020-2025)
2.4 Gastrointestinal Segment by Application
2.4.1 Chronic Gastritis
2.4.2 Functional Dyspepsia
2.4.3 Peptic Ulcer
2.4.4 Acute Gastroenteritis
2.4.5 Others
2.5 Gastrointestinal Market Size by Application
2.5.1 Gastrointestinal Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Gastrointestinal Market Size Market Share by Application (2020-2025)
3 GASTROINTESTINAL MARKET SIZE BY PLAYER
3.1 Gastrointestinal Market Size Market Share by Player
3.1.1 Global Gastrointestinal Revenue by Player (2020-2025)
3.1.2 Global Gastrointestinal Revenue Market Share by Player (2020-2025)
3.2 Global Gastrointestinal Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL BY REGION
4.1 Gastrointestinal Market Size by Region (2020-2025)
4.2 Global Gastrointestinal Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gastrointestinal Market Size Growth (2020-2025)
4.4 APAC Gastrointestinal Market Size Growth (2020-2025)
4.5 Europe Gastrointestinal Market Size Growth (2020-2025)
4.6 Middle East & Africa Gastrointestinal Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Gastrointestinal Market Size by Country (2020-2025)
5.2 Americas Gastrointestinal Market Size by Type (2020-2025)
5.3 Americas Gastrointestinal Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal Market Size by Region (2020-2025)
6.2 APAC Gastrointestinal Market Size by Type (2020-2025)
6.3 APAC Gastrointestinal Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gastrointestinal Market Size by Country (2020-2025)
7.2 Europe Gastrointestinal Market Size by Type (2020-2025)
7.3 Europe Gastrointestinal Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastrointestinal by Region (2020-2025)
8.2 Middle East & Africa Gastrointestinal Market Size by Type (2020-2025)
8.3 Middle East & Africa Gastrointestinal Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GASTROINTESTINAL MARKET FORECAST
10.1 Global Gastrointestinal Forecast by Region (2026-2031)
10.1.1 Global Gastrointestinal Forecast by Region (2026-2031)
10.1.2 Americas Gastrointestinal Forecast
10.1.3 APAC Gastrointestinal Forecast
10.1.4 Europe Gastrointestinal Forecast
10.1.5 Middle East & Africa Gastrointestinal Forecast
10.2 Americas Gastrointestinal Forecast by Country (2026-2031)
10.2.1 United States Market Gastrointestinal Forecast
10.2.2 Canada Market Gastrointestinal Forecast
10.2.3 Mexico Market Gastrointestinal Forecast
10.2.4 Brazil Market Gastrointestinal Forecast
10.3 APAC Gastrointestinal Forecast by Region (2026-2031)
10.3.1 China Gastrointestinal Market Forecast
10.3.2 Japan Market Gastrointestinal Forecast
10.3.3 Korea Market Gastrointestinal Forecast
10.3.4 Southeast Asia Market Gastrointestinal Forecast
10.3.5 India Market Gastrointestinal Forecast
10.3.6 Australia Market Gastrointestinal Forecast
10.4 Europe Gastrointestinal Forecast by Country (2026-2031)
10.4.1 Germany Market Gastrointestinal Forecast
10.4.2 France Market Gastrointestinal Forecast
10.4.3 UK Market Gastrointestinal Forecast
10.4.4 Italy Market Gastrointestinal Forecast
10.4.5 Russia Market Gastrointestinal Forecast
10.5 Middle East & Africa Gastrointestinal Forecast by Region (2026-2031)
10.5.1 Egypt Market Gastrointestinal Forecast
10.5.2 South Africa Market Gastrointestinal Forecast
10.5.3 Israel Market Gastrointestinal Forecast
10.5.4 Turkey Market Gastrointestinal Forecast
10.6 Global Gastrointestinal Forecast by Type (2026-2031)
10.7 Global Gastrointestinal Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Gastrointestinal Forecast
11 KEY PLAYERS ANALYSIS
11.1 AstraZenec
11.1.1 AstraZenec Company Information
11.1.2 AstraZenec Gastrointestinal Product Offered
11.1.3 AstraZenec Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 AstraZenec Main Business Overview
11.1.5 AstraZenec Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Gastrointestinal Product Offered
11.2.3 Sanofi Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Gastrointestinal Product Offered
11.3.3 Bayer Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Gastrointestinal Product Offered
11.4.3 Pfizer Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Gastrointestinal Product Offered
11.5.3 GlaxoSmithKline Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 Teva
11.6.1 Teva Company Information
11.6.2 Teva Gastrointestinal Product Offered
11.6.3 Teva Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Teva Main Business Overview
11.6.5 Teva Latest Developments
11.7 Zeria?Tillotts?
11.7.1 Zeria?Tillotts? Company Information
11.7.2 Zeria?Tillotts? Gastrointestinal Product Offered
11.7.3 Zeria?Tillotts? Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Zeria?Tillotts? Main Business Overview
11.7.5 Zeria?Tillotts? Latest Developments
11.8 Perrigo
11.8.1 Perrigo Company Information
11.8.2 Perrigo Gastrointestinal Product Offered
11.8.3 Perrigo Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Perrigo Main Business Overview
11.8.5 Perrigo Latest Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Information
11.9.2 Boehringer Ingelheim Gastrointestinal Product Offered
11.9.3 Boehringer Ingelheim Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Boehringer Ingelheim Main Business Overview
11.9.5 Boehringer Ingelheim Latest Developments
11.10 Purdue Pharma
11.10.1 Purdue Pharma Company Information
11.10.2 Purdue Pharma Gastrointestinal Product Offered
11.10.3 Purdue Pharma Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Purdue Pharma Main Business Overview
11.10.5 Purdue Pharma Latest Developments
11.11 C.B. Fleet
11.11.1 C.B. Fleet Company Information
11.11.2 C.B. Fleet Gastrointestinal Product Offered
11.11.3 C.B. Fleet Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 C.B. Fleet Main Business Overview
11.11.5 C.B. Fleet Latest Developments
11.12 Abbott
11.12.1 Abbott Company Information
11.12.2 Abbott Gastrointestinal Product Offered
11.12.3 Abbott Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Abbott Main Business Overview
11.12.5 Abbott Latest Developments
11.13 Jiangzhong
11.13.1 Jiangzhong Company Information
11.13.2 Jiangzhong Gastrointestinal Product Offered
11.13.3 Jiangzhong Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Jiangzhong Main Business Overview
11.13.5 Jiangzhong Latest Developments
11.14 Xian-Janssen
11.14.1 Xian-Janssen Company Information
11.14.2 Xian-Janssen Gastrointestinal Product Offered
11.14.3 Xian-Janssen Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Xian-Janssen Main Business Overview
11.14.5 Xian-Janssen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Gastrointestinal Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Gastrointestinal Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Prescription Gastrointestinal Drug
Table 4. Major Players of OTC Gastrointestinal Drug
Table 5. Gastrointestinal Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Gastrointestinal Market Size byType (2020-2025) & ($ millions)
Table 7. Global Gastrointestinal Market Size Market Share byType (2020-2025)
Table 8. Gastrointestinal Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Gastrointestinal Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Gastrointestinal Market Size Market Share by Application (2020-2025)
Table 11. Global Gastrointestinal Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Gastrointestinal Revenue Market Share by Player (2020-2025)
Table 13. Gastrointestinal Key Players Head office and Products Offered
Table 14. Gastrointestinal Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gastrointestinal Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Gastrointestinal Market Size Market Share by Region (2020-2025)
Table 19. Global Gastrointestinal Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Gastrointestinal Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Gastrointestinal Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Gastrointestinal Market Size Market Share by Country (2020-2025)
Table 23. Americas Gastrointestinal Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Gastrointestinal Market Size Market Share byType (2020-2025)
Table 25. Americas Gastrointestinal Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Gastrointestinal Market Size Market Share by Application (2020-2025)
Table 27. APAC Gastrointestinal Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Gastrointestinal Market Size Market Share by Region (2020-2025)
Table 29. APAC Gastrointestinal Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Gastrointestinal Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Gastrointestinal Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Gastrointestinal Market Size Market Share by Country (2020-2025)
Table 33. Europe Gastrointestinal Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Gastrointestinal Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Gastrointestinal Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Gastrointestinal Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Gastrointestinal Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gastrointestinal
Table 39. Key Market Challenges & Risks of Gastrointestinal
Table 40. Key IndustryTrends of Gastrointestinal
Table 41. Global Gastrointestinal Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Gastrointestinal Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Gastrointestinal Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Gastrointestinal Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. AstraZenec Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 46. AstraZenec Gastrointestinal Product Offered
Table 47. AstraZenec Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. AstraZenec Main Business
Table 49. AstraZenec Latest Developments
Table 50. Sanofi Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 51. Sanofi Gastrointestinal Product Offered
Table 52. Sanofi Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Sanofi Main Business
Table 54. Sanofi Latest Developments
Table 55. Bayer Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 56. Bayer Gastrointestinal Product Offered
Table 57. Bayer Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Bayer Main Business
Table 59. Bayer Latest Developments
Table 60. Pfizer Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 61. Pfizer Gastrointestinal Product Offered
Table 62. Pfizer Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Pfizer Main Business
Table 64. Pfizer Latest Developments
Table 65. GlaxoSmithKline Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 66. GlaxoSmithKline Gastrointestinal Product Offered
Table 67. GlaxoSmithKline Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. GlaxoSmithKline Main Business
Table 69. GlaxoSmithKline Latest Developments
Table 70.Teva Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 71.Teva Gastrointestinal Product Offered
Table 72.Teva Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73.Teva Main Business
Table 74.Teva Latest Developments
Table 75. Zeria?Tillotts? Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 76. Zeria?Tillotts? Gastrointestinal Product Offered
Table 77. Zeria?Tillotts? Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Zeria?Tillotts? Main Business
Table 79. Zeria?Tillotts? Latest Developments
Table 80. Perrigo Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 81. Perrigo Gastrointestinal Product Offered
Table 82. Perrigo Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Perrigo Main Business
Table 84. Perrigo Latest Developments
Table 85. Boehringer Ingelheim Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 86. Boehringer Ingelheim Gastrointestinal Product Offered
Table 87. Boehringer Ingelheim Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Boehringer Ingelheim Main Business
Table 89. Boehringer Ingelheim Latest Developments
Table 90. Purdue Pharma Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 91. Purdue Pharma Gastrointestinal Product Offered
Table 92. Purdue Pharma Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Purdue Pharma Main Business
Table 94. Purdue Pharma Latest Developments
Table 95. C.B.Fleet Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 96. C.B.Fleet Gastrointestinal Product Offered
Table 97. C.B.Fleet Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. C.B.Fleet Main Business
Table 99. C.B.Fleet Latest Developments
Table 100. Abbott Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 101. Abbott Gastrointestinal Product Offered
Table 102. Abbott Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Abbott Main Business
Table 104. Abbott Latest Developments
Table 105. Jiangzhong Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 106. Jiangzhong Gastrointestinal Product Offered
Table 107. Jiangzhong Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Jiangzhong Main Business
Table 109. Jiangzhong Latest Developments
Table 110. Xian-Janssen Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 111. Xian-Janssen Gastrointestinal Product Offered
Table 112. Xian-Janssen Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Xian-Janssen Main Business
Table 114. Xian-Janssen Latest Developments
LIST OFFIGURES
Figure 1. Gastrointestinal Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gastrointestinal Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Gastrointestinal Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Gastrointestinal Sales Market Share by Country/Region (2024)
Figure 8. Gastrointestinal Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Gastrointestinal Market Size Market Share byType in 2024
Figure 10. Gastrointestinal in Chronic Gastritis
Figure 11. Global Gastrointestinal Market: Chronic Gastritis (2020-2025) & ($ millions)
Figure 12. Gastrointestinal inFunctional Dyspepsia
Figure 13. Global Gastrointestinal Market:Functional Dyspepsia (2020-2025) & ($ millions)
Figure 14. Gastrointestinal in Peptic Ulcer
Figure 15. Global Gastrointestinal Market: Peptic Ulcer (2020-2025) & ($ millions)
Figure 16. Gastrointestinal in Acute Gastroenteritis
Figure 17. Global Gastrointestinal Market: Acute Gastroenteritis (2020-2025) & ($ millions)
Figure 18. Gastrointestinal in Others
Figure 19. Global Gastrointestinal Market: Others (2020-2025) & ($ millions)
Figure 20. Global Gastrointestinal Market Size Market Share by Application in 2024
Figure 21. Global Gastrointestinal Revenue Market Share by Player in 2024
Figure 22. Global Gastrointestinal Market Size Market Share by Region (2020-2025)
Figure 23. Americas Gastrointestinal Market Size 2020-2025 ($ millions)
Figure 24. APAC Gastrointestinal Market Size 2020-2025 ($ millions)
Figure 25. Europe Gastrointestinal Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Gastrointestinal Market Size 2020-2025 ($ millions)
Figure 27. Americas Gastrointestinal Value Market Share by Country in 2024
Figure 28. United States Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Gastrointestinal Market Size Market Share by Region in 2024
Figure 33. APAC Gastrointestinal Market Size Market Share byType (2020-2025)
Figure 34. APAC Gastrointestinal Market Size Market Share by Application (2020-2025)
Figure 35. China Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 39. India Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Gastrointestinal Market Size Market Share by Country in 2024
Figure 42. Europe Gastrointestinal Market Size Market Share byType (2020-2025)
Figure 43. Europe Gastrointestinal Market Size Market Share by Application (2020-2025)
Figure 44. Germany Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 45.France Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Gastrointestinal Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Gastrointestinal Market Size Market Share byType (2020-2025)
Figure 51. Middle East & Africa Gastrointestinal Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 55.Turkey Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 58. APAC Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 59. Europe Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 61. United States Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 62. Canada Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 63. Mexico Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 64. Brazil Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 65. China Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 66. Japan Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 67. Korea Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 69. India Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 70. Australia Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 71. Germany Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 72.France Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 73. UK Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 74. Italy Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 75. Russia Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 76. Egypt Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 77. South Africa Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 78. Israel Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 79.Turkey Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 80. Global Gastrointestinal Market Size Market ShareForecast byType (2026-2031)
Figure 81. Global Gastrointestinal Market Size Market ShareForecast by Application (2026-2031)
Figure 82. GCC Countries Gastrointestinal Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastrointestinal Market Size (2020-2031)
2.1.2 Gastrointestinal Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Gastrointestinal by Country/Region (2020, 2024 & 2031)
2.2 Gastrointestinal Segment by Type
2.2.1 Prescription Gastrointestinal Drug
2.2.2 OTC Gastrointestinal Drug
2.3 Gastrointestinal Market Size by Type
2.3.1 Gastrointestinal Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Gastrointestinal Market Size Market Share by Type (2020-2025)
2.4 Gastrointestinal Segment by Application
2.4.1 Chronic Gastritis
2.4.2 Functional Dyspepsia
2.4.3 Peptic Ulcer
2.4.4 Acute Gastroenteritis
2.4.5 Others
2.5 Gastrointestinal Market Size by Application
2.5.1 Gastrointestinal Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Gastrointestinal Market Size Market Share by Application (2020-2025)
3 GASTROINTESTINAL MARKET SIZE BY PLAYER
3.1 Gastrointestinal Market Size Market Share by Player
3.1.1 Global Gastrointestinal Revenue by Player (2020-2025)
3.1.2 Global Gastrointestinal Revenue Market Share by Player (2020-2025)
3.2 Global Gastrointestinal Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL BY REGION
4.1 Gastrointestinal Market Size by Region (2020-2025)
4.2 Global Gastrointestinal Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gastrointestinal Market Size Growth (2020-2025)
4.4 APAC Gastrointestinal Market Size Growth (2020-2025)
4.5 Europe Gastrointestinal Market Size Growth (2020-2025)
4.6 Middle East & Africa Gastrointestinal Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Gastrointestinal Market Size by Country (2020-2025)
5.2 Americas Gastrointestinal Market Size by Type (2020-2025)
5.3 Americas Gastrointestinal Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal Market Size by Region (2020-2025)
6.2 APAC Gastrointestinal Market Size by Type (2020-2025)
6.3 APAC Gastrointestinal Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gastrointestinal Market Size by Country (2020-2025)
7.2 Europe Gastrointestinal Market Size by Type (2020-2025)
7.3 Europe Gastrointestinal Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastrointestinal by Region (2020-2025)
8.2 Middle East & Africa Gastrointestinal Market Size by Type (2020-2025)
8.3 Middle East & Africa Gastrointestinal Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GASTROINTESTINAL MARKET FORECAST
10.1 Global Gastrointestinal Forecast by Region (2026-2031)
10.1.1 Global Gastrointestinal Forecast by Region (2026-2031)
10.1.2 Americas Gastrointestinal Forecast
10.1.3 APAC Gastrointestinal Forecast
10.1.4 Europe Gastrointestinal Forecast
10.1.5 Middle East & Africa Gastrointestinal Forecast
10.2 Americas Gastrointestinal Forecast by Country (2026-2031)
10.2.1 United States Market Gastrointestinal Forecast
10.2.2 Canada Market Gastrointestinal Forecast
10.2.3 Mexico Market Gastrointestinal Forecast
10.2.4 Brazil Market Gastrointestinal Forecast
10.3 APAC Gastrointestinal Forecast by Region (2026-2031)
10.3.1 China Gastrointestinal Market Forecast
10.3.2 Japan Market Gastrointestinal Forecast
10.3.3 Korea Market Gastrointestinal Forecast
10.3.4 Southeast Asia Market Gastrointestinal Forecast
10.3.5 India Market Gastrointestinal Forecast
10.3.6 Australia Market Gastrointestinal Forecast
10.4 Europe Gastrointestinal Forecast by Country (2026-2031)
10.4.1 Germany Market Gastrointestinal Forecast
10.4.2 France Market Gastrointestinal Forecast
10.4.3 UK Market Gastrointestinal Forecast
10.4.4 Italy Market Gastrointestinal Forecast
10.4.5 Russia Market Gastrointestinal Forecast
10.5 Middle East & Africa Gastrointestinal Forecast by Region (2026-2031)
10.5.1 Egypt Market Gastrointestinal Forecast
10.5.2 South Africa Market Gastrointestinal Forecast
10.5.3 Israel Market Gastrointestinal Forecast
10.5.4 Turkey Market Gastrointestinal Forecast
10.6 Global Gastrointestinal Forecast by Type (2026-2031)
10.7 Global Gastrointestinal Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Gastrointestinal Forecast
11 KEY PLAYERS ANALYSIS
11.1 AstraZenec
11.1.1 AstraZenec Company Information
11.1.2 AstraZenec Gastrointestinal Product Offered
11.1.3 AstraZenec Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 AstraZenec Main Business Overview
11.1.5 AstraZenec Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Gastrointestinal Product Offered
11.2.3 Sanofi Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Gastrointestinal Product Offered
11.3.3 Bayer Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Gastrointestinal Product Offered
11.4.3 Pfizer Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Gastrointestinal Product Offered
11.5.3 GlaxoSmithKline Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 Teva
11.6.1 Teva Company Information
11.6.2 Teva Gastrointestinal Product Offered
11.6.3 Teva Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Teva Main Business Overview
11.6.5 Teva Latest Developments
11.7 Zeria?Tillotts?
11.7.1 Zeria?Tillotts? Company Information
11.7.2 Zeria?Tillotts? Gastrointestinal Product Offered
11.7.3 Zeria?Tillotts? Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Zeria?Tillotts? Main Business Overview
11.7.5 Zeria?Tillotts? Latest Developments
11.8 Perrigo
11.8.1 Perrigo Company Information
11.8.2 Perrigo Gastrointestinal Product Offered
11.8.3 Perrigo Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Perrigo Main Business Overview
11.8.5 Perrigo Latest Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Information
11.9.2 Boehringer Ingelheim Gastrointestinal Product Offered
11.9.3 Boehringer Ingelheim Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Boehringer Ingelheim Main Business Overview
11.9.5 Boehringer Ingelheim Latest Developments
11.10 Purdue Pharma
11.10.1 Purdue Pharma Company Information
11.10.2 Purdue Pharma Gastrointestinal Product Offered
11.10.3 Purdue Pharma Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Purdue Pharma Main Business Overview
11.10.5 Purdue Pharma Latest Developments
11.11 C.B. Fleet
11.11.1 C.B. Fleet Company Information
11.11.2 C.B. Fleet Gastrointestinal Product Offered
11.11.3 C.B. Fleet Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 C.B. Fleet Main Business Overview
11.11.5 C.B. Fleet Latest Developments
11.12 Abbott
11.12.1 Abbott Company Information
11.12.2 Abbott Gastrointestinal Product Offered
11.12.3 Abbott Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Abbott Main Business Overview
11.12.5 Abbott Latest Developments
11.13 Jiangzhong
11.13.1 Jiangzhong Company Information
11.13.2 Jiangzhong Gastrointestinal Product Offered
11.13.3 Jiangzhong Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Jiangzhong Main Business Overview
11.13.5 Jiangzhong Latest Developments
11.14 Xian-Janssen
11.14.1 Xian-Janssen Company Information
11.14.2 Xian-Janssen Gastrointestinal Product Offered
11.14.3 Xian-Janssen Gastrointestinal Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Xian-Janssen Main Business Overview
11.14.5 Xian-Janssen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Gastrointestinal Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Gastrointestinal Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Prescription Gastrointestinal Drug
Table 4. Major Players of OTC Gastrointestinal Drug
Table 5. Gastrointestinal Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Gastrointestinal Market Size byType (2020-2025) & ($ millions)
Table 7. Global Gastrointestinal Market Size Market Share byType (2020-2025)
Table 8. Gastrointestinal Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Gastrointestinal Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Gastrointestinal Market Size Market Share by Application (2020-2025)
Table 11. Global Gastrointestinal Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Gastrointestinal Revenue Market Share by Player (2020-2025)
Table 13. Gastrointestinal Key Players Head office and Products Offered
Table 14. Gastrointestinal Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gastrointestinal Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Gastrointestinal Market Size Market Share by Region (2020-2025)
Table 19. Global Gastrointestinal Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Gastrointestinal Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Gastrointestinal Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Gastrointestinal Market Size Market Share by Country (2020-2025)
Table 23. Americas Gastrointestinal Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Gastrointestinal Market Size Market Share byType (2020-2025)
Table 25. Americas Gastrointestinal Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Gastrointestinal Market Size Market Share by Application (2020-2025)
Table 27. APAC Gastrointestinal Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Gastrointestinal Market Size Market Share by Region (2020-2025)
Table 29. APAC Gastrointestinal Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Gastrointestinal Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Gastrointestinal Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Gastrointestinal Market Size Market Share by Country (2020-2025)
Table 33. Europe Gastrointestinal Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Gastrointestinal Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Gastrointestinal Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Gastrointestinal Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Gastrointestinal Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gastrointestinal
Table 39. Key Market Challenges & Risks of Gastrointestinal
Table 40. Key IndustryTrends of Gastrointestinal
Table 41. Global Gastrointestinal Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Gastrointestinal Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Gastrointestinal Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Gastrointestinal Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. AstraZenec Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 46. AstraZenec Gastrointestinal Product Offered
Table 47. AstraZenec Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. AstraZenec Main Business
Table 49. AstraZenec Latest Developments
Table 50. Sanofi Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 51. Sanofi Gastrointestinal Product Offered
Table 52. Sanofi Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Sanofi Main Business
Table 54. Sanofi Latest Developments
Table 55. Bayer Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 56. Bayer Gastrointestinal Product Offered
Table 57. Bayer Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Bayer Main Business
Table 59. Bayer Latest Developments
Table 60. Pfizer Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 61. Pfizer Gastrointestinal Product Offered
Table 62. Pfizer Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Pfizer Main Business
Table 64. Pfizer Latest Developments
Table 65. GlaxoSmithKline Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 66. GlaxoSmithKline Gastrointestinal Product Offered
Table 67. GlaxoSmithKline Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. GlaxoSmithKline Main Business
Table 69. GlaxoSmithKline Latest Developments
Table 70.Teva Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 71.Teva Gastrointestinal Product Offered
Table 72.Teva Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73.Teva Main Business
Table 74.Teva Latest Developments
Table 75. Zeria?Tillotts? Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 76. Zeria?Tillotts? Gastrointestinal Product Offered
Table 77. Zeria?Tillotts? Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Zeria?Tillotts? Main Business
Table 79. Zeria?Tillotts? Latest Developments
Table 80. Perrigo Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 81. Perrigo Gastrointestinal Product Offered
Table 82. Perrigo Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Perrigo Main Business
Table 84. Perrigo Latest Developments
Table 85. Boehringer Ingelheim Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 86. Boehringer Ingelheim Gastrointestinal Product Offered
Table 87. Boehringer Ingelheim Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Boehringer Ingelheim Main Business
Table 89. Boehringer Ingelheim Latest Developments
Table 90. Purdue Pharma Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 91. Purdue Pharma Gastrointestinal Product Offered
Table 92. Purdue Pharma Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Purdue Pharma Main Business
Table 94. Purdue Pharma Latest Developments
Table 95. C.B.Fleet Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 96. C.B.Fleet Gastrointestinal Product Offered
Table 97. C.B.Fleet Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. C.B.Fleet Main Business
Table 99. C.B.Fleet Latest Developments
Table 100. Abbott Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 101. Abbott Gastrointestinal Product Offered
Table 102. Abbott Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Abbott Main Business
Table 104. Abbott Latest Developments
Table 105. Jiangzhong Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 106. Jiangzhong Gastrointestinal Product Offered
Table 107. Jiangzhong Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Jiangzhong Main Business
Table 109. Jiangzhong Latest Developments
Table 110. Xian-Janssen Details, CompanyType, Gastrointestinal Area Served and Its Competitors
Table 111. Xian-Janssen Gastrointestinal Product Offered
Table 112. Xian-Janssen Gastrointestinal Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Xian-Janssen Main Business
Table 114. Xian-Janssen Latest Developments
LIST OFFIGURES
Figure 1. Gastrointestinal Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gastrointestinal Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Gastrointestinal Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Gastrointestinal Sales Market Share by Country/Region (2024)
Figure 8. Gastrointestinal Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Gastrointestinal Market Size Market Share byType in 2024
Figure 10. Gastrointestinal in Chronic Gastritis
Figure 11. Global Gastrointestinal Market: Chronic Gastritis (2020-2025) & ($ millions)
Figure 12. Gastrointestinal inFunctional Dyspepsia
Figure 13. Global Gastrointestinal Market:Functional Dyspepsia (2020-2025) & ($ millions)
Figure 14. Gastrointestinal in Peptic Ulcer
Figure 15. Global Gastrointestinal Market: Peptic Ulcer (2020-2025) & ($ millions)
Figure 16. Gastrointestinal in Acute Gastroenteritis
Figure 17. Global Gastrointestinal Market: Acute Gastroenteritis (2020-2025) & ($ millions)
Figure 18. Gastrointestinal in Others
Figure 19. Global Gastrointestinal Market: Others (2020-2025) & ($ millions)
Figure 20. Global Gastrointestinal Market Size Market Share by Application in 2024
Figure 21. Global Gastrointestinal Revenue Market Share by Player in 2024
Figure 22. Global Gastrointestinal Market Size Market Share by Region (2020-2025)
Figure 23. Americas Gastrointestinal Market Size 2020-2025 ($ millions)
Figure 24. APAC Gastrointestinal Market Size 2020-2025 ($ millions)
Figure 25. Europe Gastrointestinal Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Gastrointestinal Market Size 2020-2025 ($ millions)
Figure 27. Americas Gastrointestinal Value Market Share by Country in 2024
Figure 28. United States Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Gastrointestinal Market Size Market Share by Region in 2024
Figure 33. APAC Gastrointestinal Market Size Market Share byType (2020-2025)
Figure 34. APAC Gastrointestinal Market Size Market Share by Application (2020-2025)
Figure 35. China Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 39. India Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Gastrointestinal Market Size Market Share by Country in 2024
Figure 42. Europe Gastrointestinal Market Size Market Share byType (2020-2025)
Figure 43. Europe Gastrointestinal Market Size Market Share by Application (2020-2025)
Figure 44. Germany Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 45.France Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Gastrointestinal Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Gastrointestinal Market Size Market Share byType (2020-2025)
Figure 51. Middle East & Africa Gastrointestinal Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 55.Turkey Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Gastrointestinal Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 58. APAC Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 59. Europe Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 61. United States Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 62. Canada Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 63. Mexico Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 64. Brazil Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 65. China Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 66. Japan Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 67. Korea Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 69. India Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 70. Australia Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 71. Germany Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 72.France Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 73. UK Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 74. Italy Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 75. Russia Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 76. Egypt Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 77. South Africa Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 78. Israel Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 79.Turkey Gastrointestinal Market Size 2026-2031 ($ millions)
Figure 80. Global Gastrointestinal Market Size Market ShareForecast byType (2026-2031)
Figure 81. Global Gastrointestinal Market Size Market ShareForecast by Application (2026-2031)
Figure 82. GCC Countries Gastrointestinal Market Size 2026-2031 ($ millions)
More Publications
Global Steroid-Corticosteroids Market Growth 2025-2031
US$ 3,660.00
December 2024
86 pages
Global Blood Bags Market Growth 2025-2031
US$ 3,660.00
December 2024
120 pages
Global Hydroalcoholic Gel Market Growth 2025-2031
US$ 3,660.00
December 2025
97 pages
Global Acquired Infections Testing Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
116 pages
Global Skin Ulcer Wound Care Products Market Growth 2024-2030
US$ 3,660.00
March 2024
109 pages
